A role for DCs present at the tumor site is supported by their ability to internalize immune complexes via activating FcγR and to promote efficient MHC II- and MHC I-restricted presentation of peptides from exogenous IgG-complexed antigens (57–59). This evidence concerns the gene FCGR2A and neoplasm.